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symptomatic stage of LF/LG AS.10 In this set‑
ting, aortic valve replacement is the only thera‑
py that improves outcomes.10,11 Transcatheter aor‑
tic valve replacement has an ever ‑expanding role 
in the treatment of AS, and there is growing evi‑
dence that it may be a preferred therapeutic op‑
tion for low ‑flow AS states.11,12 
A rare but diagnostically difficult condition is 
also pseudo ‑severe AS, in which severe LV dys‑
function results in a low aortic flow rate, and 
the semicompliant aortic valve cannot open. As 
a consequence, estimated AVA values are inade‑
quately low and surgery most probably does not 
improve outcomes, which is mainly related to se‑
vere heart failure due to LV damage. Mistakes in 
AVA calculation due to the oval shape of the LV 
outflow tract are also common in everyday prac‑
tice, causing difficulties in aortic valve assess‑
ment. Thus, the diagnostic workup of current AS 
population has become more demanding than 
ever before, and continuing training in this field 
is needed. In difficult cases, it is recommended to 
concomitantly use other imaging techniques (eg, 
transesophageal echocardiography, computed to‑
mography, cardiac magnetic resonance), which 
may be superior to transthoracic echocardiogra‑
phy. This may help optimize the assessment of 
the valves, cardiac chambers, and the function‑
al status of the myocardium and facilitate prop‑
er decision making process.13
On the other hand, recent years have brought a 
rapid development of minimally invasive methods 
for the treatment of AS (minimally invasive aortic 
valve replacement, and particularly transcatheter 
aortic valve implantation [TAVI]). This has opened 
a less risky way to treat the disease even in old pa‑
tients with comorbidities, who would have been 
considered inoperable 10 years ago.11,14-16 With im‑
provements in technology and implantation skills, 
the complication rate has decreased significantly, 
and the procedure may now be considered even 
in moderate‑risk patients.17 The number of TAVI 
procedures in Poland has been slowly increasing, 
but it does not match the growing population of 
AS patients at high risk of a conventional surgery.
Aortic stenosis (AS) is currently the most frequent 
valvular disorder in aging populations of the de‑
veloped countries. A rheumatic etiology has be‑
come rare, while a degenerative form has been 
systematically more prevalent. As a result, up 
to 4% of the population over the age of 65 years 
suffers from AS.1-4 
The current issue of the Polish Archives of Inter-
nal Medicine (Pol Arch Intern Med) contains an in‑
teresting paper by Roleder et al,5 which confirms 
the high prevalence of AS among patients hos‑
pitalized in the Silesian region in Poland dur‑
ing the last 10 years. A total of 605 920 patients 
were enrolled in a prospective registry, of whom 
15 158 (2.5%) had a diagnosis of AS. Importantly, 
the percentage of AS patients rised from 0.95% 
in 2006 to 4.64% in 2016 (P <0.001). Currently, 
the mean life expectancy in Poland is 74 years 
for men and 82 years for women, and it has in‑
creased during the past 10 years by approximate‑
ly 3.1 years.6 This is probably the major reason for 
a rise in the number of AS cases. Another cause 
may be a more accurate diagnosis due to improved 
access to echocardiography and better skills of 
echocardiographers. 
The recognition of low ‑flow low ‑gradient AS 
(LF/LG AS), a condition in which no typical AS 
murmur is audible due to decreased left ventric‑
ular (LV) function and low‑flow velocities, is chal‑
lenging.7,8 It is particularly true in the case of par‑
adoxical LF/LG AS, in which an aortic pressure 
gradient is unexpectedly low despite preserved 
LV ejection fraction. This condition was first de‑
scribed by Hachicha et al9,10 in 2007. The registry5 
was started before this discovery, and, most prob‑
ably, the definition of paradoxical LF/LG AS was 
adopted in the late phase of the registry. The prev‑
alence of LF/LG AS ranges from 10% to 40% of 
AS patients. In the KRAK ‑AS registry includ‑
ing 653 patients with AS, a mismatch between 
the transvalvular gradient and aortic valve area 
was found in 22% of cases (unpublished data).
It is known that a severe limitation of aortic 
valve opening (AVA index <0.6 cm2/m2) is linked 
to a very poor prognosis, particularly at  the 
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Apart from population growth, AS patients are 
also becoming older and have more and more co‑
morbidities. As a result, they may be treated in 
different hospital wards. The registry5 showed 
that 29% of AS patients were hospitalized in in‑
ternal medicine wards; thus, detailed diagnosis 
is needed also outside specialized cardiology de‑
partments. Interestingly, 27.6% of AS patients 
had concomitant heart failure. This is the second 
growing problem in current AS populations world‑
wide, including Poland, and can result either from 
decompensated AS or an independent disease as‑
sociated with myocardial damage (most frequent‑
ly coronary artery disease, present in 41% of AS 
patients). Anyway, the coexistence of AS and HF 
is a deadly duet associated with a particularly 
poor prognosis and requiring prompt treatment. 
If the treatment is applied before irreversible LV 
damage, a significant improvement is possible. 
The registry5 revealed a rising number of percu‑
taneous coronary interventions (PCIs) compared 
with a decreasing number of coronary artery by‑
pass graft surgeries. This can be caused by the in‑
creasing use of staged procedures, for example, a 
PCI followed by TAVI.
In the reported series,5 3.24% of AS patients 
died during hospitalization. However, the in‑
‑hospital mortality rate dropped from 4.5% in 
2006 to 3.0% in 2016 (P = 0.02), confirming an 
improvement of care despite higher disease com‑
plexity observed in those patients. On the other 
hand, the 1‑year mortality rate was higher, show‑
ing an increasing trend from 14.3% in 2006 to 
16% in 2015 (P = 0.07).
Probably, a substantial number of patients in 
the registry had moderate AS, as only approximate‑
ly 25% of them had the valve implanted. The regis‑
try5 was based only on basic information, such as 
an International Classification of Diseases code, and 
did not account for differences in the severity or 
type of AS. Such subanalyses would be of great val‑
ue. Nonetheless, the paper is an important source 
of epidemiological data based on a very large cohort 
of hospitalized patients. The high prevalence of 
AS, together with a dynamic increase over the last 
10 years, shows that hospitals should be prepared 
for a higher number of AS patients, while physi‑
cians should be more alert as the disease may de‑
velop slowly, with symptoms of heart failure mask‑
ing the valvular problem. Continuing training in 
a detailed evaluation of AS patients should be en‑
couraged. The expected number of valvular pro‑
cedures, particularly in elderly patients, will most 
probably further increase, which means yet anoth‑
er challenge for the health care system. 
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